Nuvation Bio Inc.

About Nuvation Bio Inc.

Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment. Their mission is to develop and commercialize new generations of oncology medicines that improve patient outcomes by addressing drug resistance and limited efficacy of current therapies, while reducing side effects and preserving quality of life.

Products & Services

IBTROZI™ (taletrectinib):A next-generation oral treatment for advanced ROS1-positive non-small cell lung cancer, recently FDA-approved.

Specialties

Development of novel oncology therapies Targeting difficult-to-treat cancers Addressing drug resistance in cancer treatment Improving outcomes for ROS1-positive non-small cell lung cancer

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Non-dilutive financings (Royalty interest and Debt) T: - FT: Non-dilutive financings (Royalty interest and Debt)	A: 250000000 MR: - FA: up to $250 million FAN: 250000000	D: 2025-03-03 FD: 2025-03-03	1 investors

Non-dilutive financings (Royalty interest and Debt) Latest

2025-03-03

$250.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

W

Wassim Abida

Director of Translational Research in Prostate Cancer and Associate Attending Physician of Genitourinary Oncology

J

Johann de Bono

Regius Professor of Cancer Research and Professor in Experimental Cancer Medicine

G

Gordon B. Mills

Director of Precision Oncology and SMMART trials

M

Mansoor Raza Mirza

Chief Oncologist

A

Allyson Ocean

Medical Oncologist and Attending Physician in Gastrointestinal Oncology

J

Joyce O'Shaughnessy

Celebrating Women Endowed Chair in Breast Cancer Research, Baylor University Medical Center, Texas Oncology and Chair, Breast Cancer Research, US Oncology Research Network

View 19 more team members with Pro

Unlock Full Team Directory

Recent News

Nuvation Bio Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised